New initiatives in the treatment of myeloma
Marginalized and high-risk multiple myeloma patients: how to address this issue
Primary analysis of MURANO study data for R/R CLL
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Allogeneic transplant is not the quintessential treatment for ALL anymore!